课题基金 / 基金详情

项目摘要

项目成果

KENNETH M LANGA的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT The primary aim of the Health and Retirement Study (HRS) cooperative agreement is to collect and distribute multi-disciplinary data to support research on aging. Cognitive impairment and dementia, including Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD), impose enormous burdens on families and government policies. To provide the research community with new and richer data to study the prevalence, predictors, and outcomes of cognitive impairment and dementia, we undertook the HRS Harmonized Cognitive Assessment Protocol (HCAP) Study during the HRS 2016 field period, in which we administered a supplemental in-home 1-hour battery of cognitive tests to about 3,200 randomly selected and nationally representative HRS respondents aged 65+, as well as a 20-minute informant interview. In the proposed HCAP 2020 follow-up study, we will re-administer the same HCAP in-home cognitive assessment and informant report to all surviving members of the original HCAP sample (n ~ 2,250), and to a new random sample of those aged 65 to 68 in 2020 (n ~ 720). The HCAP 2020 follow-up study will provide extensive new data to better assess trajectories of cognitive decline among older US adults, including the incidence of new cognitive impairment and dementia. These data will also provide an unprecedented opportunity to better understand trends in the incidence and prevalence of dementia in the US and around the world.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Network for the Harmonized Cognitive Assessment Protocol (HCAP)
Research Network for the Harmonized Cognitive Assessment Protocol (HCAP)
Research Network for the Harmonized Cognitive Assessment Protocol (HCAP)
Research Network for the Harmonized Cognitive Assessment Protocol (HCAP)
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: